Cite
HARVARD Citation
Gavriatopoulou, M. et al. (2022). Myeloma patients with COVID‐19 have superior antibody responses compared to patients fully vaccinated with the BNT162b2 vaccine. British journal of haematology. pp. 356-359. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gavriatopoulou, M. et al. (2022). Myeloma patients with COVID‐19 have superior antibody responses compared to patients fully vaccinated with the BNT162b2 vaccine. British journal of haematology. pp. 356-359. [Online].